Rosselkhoznadzor, Russia's agriculture safety watchdog, stated that Russia has registered the world's first COVID-19 vaccine for animals, Reuters news agency reported on Wednesday.
Developed by a unit of Rosselkhoznadzor, this COVID-19 vaccine for animals is named Carnivac-Cov.
Deputy Head of Rosselkhoznadzor, Konstantin Savenkov, was quoted as saying: "The clinical trials of Carnivac-Cov, which started last October, involved dogs, cats, Arctic foxes, minks, foxes and other animals. The results of the trials allow us to conclude that the vaccine is harmless and highly immunogenic as all the vaccinated animals developed antibodies to the coronavirus in 100% of cases."
Immunity lasts for six months after vaccination, but the vaccine developers are continuing to analyse this, Rosselkhoznadzor said, adding that mass production of the vaccine could start as early as April 2021.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval